{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:30:28Z","timestamp":1790368228195,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH 113-S0045"],"award-info":[{"award-number":["NTUH 113-S0045"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["J. Pharm. Pharm. Sci."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Mycophenolic acid (MPA) and tacrolimus (TAC) exhibit substantial pharmacokinetic variability, and volumetric absorptive microsampling (VAMS) offers a minimally invasive alternative for therapeutic drug monitoring (TDM). This study aimed to develop a VAMS-based method for MPA and TAC quantifications and systematically evaluate hematocrit (Hct)-adjusted conversion strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult transplant recipients receiving mycophenolate mofetil or mycophenolate sodium were prospectively enrolled. Paired plasma (MPA), whole-blood (TAC), and VAMS samples were analyzed using validated LC\u2013MS\/MS method for simultaneous MPA and TAC quantification. Multiple Hct-adjusted conversion approaches for MPA were compared using Passing-Bablok regression, Bland-Altman analysis, and predictive performance metrics. Clinical applicability was assessed through scenario-based AUC estimation MPA AUC estimations under different sampling schemes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      LC-MS\/MS method for quantifying MPA and TAC in VAMS exhibited good linearity (R\n                      <jats:sup>2<\/jats:sup>\n                      &amp;gt; 0.99) and accuracy within 85\u2013115% across validation ranges (10\u201320,000\u00a0ng\/mL for MPA; 0.5\u2013500\u00a0ng\/mL for TAC). Formula A-ind [(VAMS\/1 \u2013 individual Hct) x f\n                      <jats:sub>bpp<\/jats:sub>\n                      ], where f\n                      <jats:sub>bpp<\/jats:sub>\n                      represents the MPA protein binding fraction (0.97), achieved clinical agreement in 86% of samples for the conversion of MPA concentrations between VAMS and plasma, representing the most balanced between predictive reliability and operational feasibility. TAC concentrations from VAMS correlated strongly with whole blood values without requiring Hct correction. Clinical case applications showed that rich eight-point VAMS sampling enabled more accurate AUC estimations than conventional three-point schemes, further highlighting the advantages of using VAMS for MPA TDM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This validated VAMS-based approach offers a minimally invasive and clinically applicable alternative to venous sampling for MPA and TAC monitoring. Incorporating individualized Hct adjustments improves predictive performance, supporting conditional integration of VAMS into routine TDM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/jpps.2026.16123","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:10:21Z","timestamp":1774505421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of hematocrit-adjusted conversion strategies for mycophenolic acid and tacrolimus monitoring using volumetric absorptive microsampling in lung and renal transplant recipients"],"prefix":"10.3389","volume":"29","author":[{"given":"Liang","family":"Juan","sequence":"first","affiliation":[{"name":"School of Pharmacy, College of Medicine, National Taiwan University","place":["Taipei, Taiwan"]},{"name":"Faculty of Medicine, Graduate School of Medicine, Kyoto University","place":["Kyoto, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ning","family":"Cheng","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Medicine, National Taiwan University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chi","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Medical Research, National Taiwan University Hospital","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Hsuan","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Medical Research, National Taiwan University Hospital","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Wen","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Taiwan University Hospital and College of Medicine, National Taiwan University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsao-Hsun","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Taiwan University Hospital and College of Medicine, National Taiwan University","place":["Taipei, Taiwan"]},{"name":"Department of Surgery, National Taiwan University Cancer Center","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hua","family":"Kuo","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Medicine, National Taiwan University","place":["Taipei, Taiwan"]},{"name":"Department of Pharmacy, National Taiwan University Hospital","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ju","family":"Tseng","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Medicine, National Taiwan University","place":["Taipei, Taiwan"]},{"name":"Department of Pharmacy, National Taiwan University Hospital","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"B1","volume-title":"Transplants performed by organ","year":"2023"},{"key":"B2","volume-title":"Taiwan Organ Sharing Registry and Patient Autonomy Promotion Center","year":"2026"},{"key":"B3","volume-title":"PROGRAF (tacrolimus) capsules, for oral use, PROGRAF (tacrolimus) injection, for intravenous use, PROGRAF Granules (tacrolimus for oral suspension)","year":"2026"},{"key":"B4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monitoring"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/bcp.16098","article-title":"Therapeutic drug monitoring of tacrolimus after kidney transplantation: trough concentration or area under curve\u2010based monitoring?","volume":"91","author":"van Gelder","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"B6","volume-title":"CELLCEPT(R) oral capsules ot, oral suspension, intravenous injection, mycophenolate mofetil oral capsules, oral tablets, oral suspension, intravenous injection","year":""},{"key":"B7","volume-title":"MYFORTIC(R) oral delayed-release tablets maod-rtNPCpF","year":""},{"key":"B8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther Drug Monitoring"},{"key":"B9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2215\/CJN.07111009","article-title":"Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation","volume":"5","author":"Kuypers","year":"2010","journal-title":"Clin Journal Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00007691-200108000-00001","article-title":"Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion","volume":"23","author":"Shaw","year":"2001","journal-title":"Ther Drug Monitoring"},{"key":"B11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/s0009-9120(98)00040-x","article-title":"Therapeutic monitoring of mycophenolic acid: a consensus panel report","volume":"31","author":"Shaw","year":"1998","journal-title":"Clin Biochemistry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/01.ftd.0000199358.80013.bd","article-title":"Therapeutic drug monitoring of mycophenolate mofetil in transplantation","volume":"28","author":"Van Gelder","year":"2006","journal-title":"Ther Drug Monitoring"},{"key":"B13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.trre.2009.02.002","article-title":"Monitoring of mycophenolate mofetil in orthotopic heart transplant recipients\u2014a systematic review","volume":"23","author":"Zuk","year":"2009","journal-title":"Transplant Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.12659\/AOT.883812","article-title":"Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation","volume":"18","author":"Wu","year":"2013","journal-title":"Ann Transpl"},{"key":"B15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1517\/17425255.2016.1170806","article-title":"Therapeutic drug monitoring of mycophenolate in adult solid organ transplant patients: an update","volume":"12","author":"Kiang","year":"2016","journal-title":"Expert Opin Drug Metab & Toxicol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1185\/030079906X148481","article-title":"Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome","volume":"22","author":"Kaplan","year":"2006","journal-title":"Curr Medical Research Opinion"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1515\/cclm-2019-1260","article-title":"Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring","volume":"58","author":"Veenhof","year":"2020","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"114443","DOI":"10.1016\/j.jpba.2021.114443","article-title":"Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determination","volume":"208","author":"Paniagua-Gonz\u00e1lez","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"B19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/pharmaceutics15010299","article-title":"Therapeutic drug monitoring of tacrolimus based on volumetric absorptive microsampling technique (VAMS) in renal transplant pediatric recipients\u2014LC-MS\/MS method development, hematocrit effect evaluation, and clinical application","volume":"15","author":"Kocur","year":"2023","journal-title":"Pharmaceutics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s43440-023-00509-w","article-title":"Therapeutic drug monitoring of mycophenolic acid (MPA) using volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients: ultra-high-performance liquid chromatography-tandem mass spectrometry analytical method development, cross-validation, and clinical application","volume":"75","author":"Kocur","year":"2023","journal-title":"Pharmacol Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.3390\/molecules28166046","article-title":"Analytical and clinical validation of assays for volumetric absorptive microsampling (VAMS) of drugs in different blood matrices: a literature review","volume":"28","author":"Nugraha","year":"2023","journal-title":"Molecules"},{"key":"B22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4155\/bio-2018-0312","article-title":"A volumetric absorptive microsampling LC\u2013MS\/MS method for five immunosuppressants and their hematocrit effects","volume":"11","author":"Koster","year":"2019","journal-title":"Bioanalysis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/FTD.0000000000001066","article-title":"Volumetric absorptive microsampling to enhance the therapeutic drug monitoring of tacrolimus and mycophenolic acid: a systematic review and critical assessment","volume":"45","author":"Leino","year":"2023","journal-title":"Ther Drug Monit"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1111\/bcp.15433","article-title":"Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients","volume":"88","author":"Zwart","year":"2022","journal-title":"Br Journal Clinical Pharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jchromb.2006.12.048","article-title":"Simultaneous LC\u2013MS\u2013MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure","volume":"850","author":"Bogusz","year":"2007","journal-title":"J Chromatogr B"},{"key":"B26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jchromb.2005.11.010","article-title":"Simultaneous determination of three isomeric metabolites of tacrolimus (FK506) in human whole blood and plasma using high performance liquid chromatography\u2013tandem mass spectrometry","volume":"830","author":"Chen","year":"2006","journal-title":"J Chromatogr B"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.3390\/pharmaceutics14122547","article-title":"A volumetric absorptive microsampling UPLC-MS\/MS method for simultaneous quantification of tacrolimus, mycophenolic acid and creatinine in whole blood of renal transplant recipients","volume":"14","author":"Wang","year":"2022","journal-title":"Pharmaceutics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1111\/bcp.13755","article-title":"Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device","volume":"84","author":"Zwart","year":"2018","journal-title":"Br Journal Clinical Pharmacology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10549-014-2999-2","article-title":"Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen","volume":"146","author":"Jager","year":"2014","journal-title":"Breast Cancer Research Treatment"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/jac\/dks011","article-title":"Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz","volume":"67","author":"Kromdijk","year":"2012","journal-title":"J Antimicrobial Chemotherapy"},{"key":"B31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00228-013-1584-7","article-title":"Importance of hematocrit for a tacrolimus target concentration strategy","volume":"70","author":"St\u00f8rset","year":"2014","journal-title":"Eur Journal Clinical Pharmacology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"114623","DOI":"10.1016\/j.jpba.2022.114623","article-title":"Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratio","volume":"211","author":"Zimmermann","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"B33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/bmc.1367","article-title":"Dried blood spot sampling in combination with LC\u2010MS\/MS for quantitative analysis of small molecules","volume":"24","author":"Li","year":"2010","journal-title":"Biomed Chromatogr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/jalm\/jfaf022","article-title":"Volumetric absorptive microsampling combined with mass spectrometry to support Pharmacokinetically-Guided precision dosing of mycophenolate mofetil in pediatric lupus nephritis patients","volume":"10","author":"Zhao","year":"2025","journal-title":"The Journal Applied Laboratory Medicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/00365518809085796","article-title":"A comparison between haematological parameters in \u2018capillary\u2019and venous blood from healthy adults","volume":"48","author":"Daae","year":"1988","journal-title":"Scand Journal Clinical Laboratory Investigation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jpba.2006.08.010","article-title":"Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC\/MS\/MS method for the determination of carvedilol enantiomers in human plasma","volume":"43","author":"Wang","year":"2007","journal-title":"J Pharmaceutical Biomedical Analysis"},{"key":"B37","unstructured":"Allowable limits of performance\n          \n          \n          2014"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6904-12-2","article-title":"Validation of an LC-MS\/MS method to determine five immunosuppressants with deuterated internal standards including MPA","volume":"12","author":"Buchwald","year":"2012","journal-title":"BMC Clinical Pharmacology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2165\/11312600-000000000-00000","article-title":"Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients","volume":"48","author":"van Hest","year":"2009","journal-title":"Clin Pharmacokinetics"},{"key":"B40","volume-title":"Product Information: SULFAMETHOXAZOLE AND TRIMETHOPRIM - sulfamethoxazole and trimethoprim tablet Cronus Pharma","year":""},{"key":"B41","volume-title":"Product Monograph: VALCYTE\u00ae, Valganciclovir Film Coated tablets 450 mg (as valganciclovir hydrochloride), Valganciclovir Powder for Oral Solution 50 mg\/mL when reconstituted (as valganciclovir hydrochloride)","year":""},{"key":"B42","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1248\/bpb.29.2099","article-title":"Clinical pharmacokinetics of mycophenolate mofetil in Japanese renal transplant recipients: a retrospective cohort study in a single center","volume":"29","author":"Sugioka","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"B43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-12-800885-0.00004-7","article-title":"Monitoring free mycophenolic acid concentration: is there any clinical advantage?","volume-title":"Personalized immunosuppression in transplantation","author":"Dasgupta","year":"2016"}],"container-title":["Journal of Pharmacy &amp; Pharmaceutical Sciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/jpps.2026.16123\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:10:24Z","timestamp":1774505424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/jpps.2026.16123\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":43,"alternative-id":["10.3389\/jpps.2026.16123"],"URL":"https:\/\/doi.org\/10.3389\/jpps.2026.16123","relation":{},"ISSN":["1482-1826"],"issn-type":[{"value":"1482-1826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"article-number":"16123"}}